Serdarevic, M., Kukulj, S., Rebic, A., Drpa, G., Budimir, B., Popovic, F. ... Samarzija, M. (2017). The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes. Journal of Thoracic Oncology, 12. (S1), S1283. doi: 10.1016/j.jtho.2016.11.1814
Serdarevic, Marina, et al. "The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes." Journal of Thoracic Oncology, vol. 12, br. S1, 2017, str. S1283. https://doi.org/10.1016/j.jtho.2016.11.1814
Serdarevic, Marina, Suzana Kukulj, Ante Rebic, Gordana Drpa, Bernard Budimir, Filip Popovic, Tea Lovric, Katherina Sreter i Miroslav Samarzija. "The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes." Journal of Thoracic Oncology 12, br. S1 (2017): S1283. https://doi.org/10.1016/j.jtho.2016.11.1814
Serdarevic, M., et al. (2017) 'The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes', Journal of Thoracic Oncology, 12(S1), str. S1283. doi: 10.1016/j.jtho.2016.11.1814
Serdarevic M, Kukulj S, Rebic A, Drpa G, Budimir B, Popovic F, i sur.. The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes. Journal of Thoracic Oncology [Internet]. 01.2017. [pristupljeno 27.10.2024.];12(S1):S1283. doi: 10.1016/j.jtho.2016.11.1814
M. Serdarevic, et al., "The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung Cancer and Type 2 Diabetes", Journal of Thoracic Oncology, vol. 12, br. S1, str. S1283, Siječanj 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:220:485963. [Citirano: 27.10.2024.]